Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study
Despite some variability in ideal serum Adalimumab (ADA) concentrations, there is increasing evidence that higher concentrations of anti-TNF-α agents can be associated with sustained efficacy, and low or undetectable levels may lead to loss of response. This study aims to correlate serum ADA concent...
Saved in:
Main Authors: | Letícia Rodrigues de Souza (Author), Daniela Oliveira Magro (Author), Fábio Vieira Teixeira (Author), Rogério Serafim Parra (Author), Eron Fábio Miranda (Author), Omar Féres (Author), Rogério Saad-Hossne (Author), Giedre Soares Prates Herrerias (Author), Renato Mitsunori Nisihara (Author), Claudio Saddy Rodrigues Coy (Author), Ligia Yukie Sassaki (Author), Paulo Gustavo Kotze (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
by: Marcello Imbrizi, et al.
Published: (2023) -
Difficult-to-treat-pediatric Crohn's disease: focus on adalimumab
by: Zeisler B, et al.
Published: (2015) -
Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn's disease
by: Liang Chen, et al.
Published: (2022) -
Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease
by: Yifei Liu, et al.
Published: (2022) -
Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence
by: Celia Posada, et al.
Published: (2011)